Incremental Dialysis Decision Model Based on Expert-Guided Machine Learning
- Conditions
- End-stage Renal Disease
- Registration Number
- NCT06775067
- Lead Sponsor
- Huashan Hospital
- Brief Summary
This observational prospective study combined clinical expert knowledge with machine learning to develop and validate a predictive model for incremental hemodialysis decision-making. The aim of the predictive model is to assist clinicians in developing individualized incremental dialysis treatment plans to optimize patient outcomes.
- Detailed Description
By collecting patients' clinical and biochemical parameters and combining them with experts' judgments of dialysis timing and frequency, the model can dynamically assess patients' risk of needing to increase the frequency of dialysis, thus assisting physicians in formulating individualized incremental dialysis regimens to optimize dialysis outcomes and improve patients' prognosis.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 175
- New hemodialysis patients (Apr 2010-Jun 2024), started within 3 months, including transfers.
- Age ≥18, stable hemodialysis >6 months.
- Incomplete/unreliable data.
- Twice-weekly palliative dialysis.
- No baseline urine output or ≤200 mL/24h.
- Liver disease, heart failure, or severe comorbidities.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number (Proportion) of Participants Who Experience an Incremental Dialysis Event, Assessed Monthly Baseline and monthly visits from enrollment until incremental dialysis event, death, transfer, or up to 5 years (whichever occurs first) An incremental dialysis event is defined as an increase in a patient's dialysis frequency (e.g., from 1 session per week to 2 sessions per week, or from 2 to 3 sessions per week, etc.) due to clinical considerations such as decreased residual renal function, fluid overload, or other physician-determined criteria. At each monthly visit (up to 5 years from enrollment), investigators will record whether each participant experiences an incremental event. We will quantify the primary outcome as the number and proportion of participants who transition to a higher dialysis frequency per month, as well as the cumulative incidence over time.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Huashan hospital, Fudan university
🇨🇳Shanghai, Shanghai, China